Erratum: Patient-reported visual function outcomes improve after ranibizumab treatmentin patients with vision impairment dueto diabetic macular edema: Randomized clinical trial (JAMA Ophthalmology (2013) 131:10 (1339-1347) DOI: 10.1001/jamaophthalmol.2013.4592);Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema randomized clinical trial

JAMA Ophthalmology

Volumn 131, Issue 10, 2013, Pages 1339-1347

  Mitchell, Paul ^a   Bressler, Neil ^b   Tolley, Keith ^c   Gallagher, Meghan ^d,g   Petrillo, Jennifer ^d   Ferreira, Alberto ^d,e   Bandello, Francesco ^f  

^a UNIVERSITY OF SYDNEY   (Australia)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Tolley Health Economics   (United Kingdom)

^d NOVARTIS PHARMA AG   (Switzerland)

^e ADELPHI REAL WORLD   (United Kingdom)

^f VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^g SANOFI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

ADULT; ARTICLE; CENTRAL RETINAL THICKNESS; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; FEMALE; FOLLOW UP; HUMAN; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SOCIAL INTERACTION; TREATMENT OUTCOME; VISION; VISUAL ACUITY;

EID: 84885933408     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.7243     Document Type: Erratum

References (20)

1. Moss SE, Klein R, Klein BE. Ten-year incidence of visual loss in a diabetic population. Ophthalmology. 1994;101(6):1061-1070. (Pubitemid 24183163)
2. Paulus YM, Gariano RF. Diabetic retinopathy: a growing concern in an aging population. Geriatrics. 2009;64(2):16-20.
3. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology. 2009;116(3):497-503.
4. Chen E, Looman M, Laouri M, et al. Burden of illness of diabetic macular edema: literature review. Curr Med Res Opin. 2010;26(7):1587-1597.
5. Hariprasad SM, Mieler WF, Grassi M, Green JL, Jager RD, Miller L. Vision-related quality of life in patients with diabetic macular oedema. Br J Ophthalmol. 2008;92(1):89-92.
6. Davidov E, Breitscheidel L, Clouth J, Reips M, Happich M. Diabetic retinopathy and health-related quality of life. Graefes Arch Clin Exp Ophthalmol. 2009;247(2):267-272.
7. Hirai FE, Tielsch JM, Klein BE, Klein R. Ten-year change in vision-related quality of life in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology. 2011;118(2):353-358.
8. Bressler NM, Chang TS, Suñer IJ, et al; MARINA and ANCHOR Research Groups. Vision-related function after ranibizumab treatment by better-or worse-seeing eye: clinical trial results from MARINA and ANCHOR. Ophthalmology. 2010;117(4):747-756; e4.
9. Bressler NM, Chang TS, Fine JT, Dolan CM, Ward J; Anti-VEGF Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization in Age-Related Macular Degeneration (ANCHOR) Research Group. Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial. Arch Ophthalmol. 2009;127(1):13-21.
10. Chang TS, Bressler NM, Fine JT, Dolan CM, Ward J, Klesert TR; MARINA Study Group. Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 2007;125(11):1460-1469. (Pubitemid 350106676)
11. Mitchell P, Bandello F, Schmidt-Erfurth U, et al; RESTORE study group. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118(4):615-625.
12. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD; National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119(7):1050-1058. (Pubitemid 32652197)
13. Suñer IJ, Kokame GT, Yu E, Ward J, Dolan C, Bressler NM. Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials. Invest Ophthalmol Vis Sci. 2009;50(8):3629-3635.
14. Gabrielian A, Hariprasad SM, Jager RD, Green JL, Mieler WF. The utility of visual function questionnaire in the assessment of the impact of diabetic retinopathy on vision-related quality of life. Eye (Lond). 2010;24(1):29-35.
15. Orr P, Rentz AM, Margolis MK, et al. Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52(6):3354-3359.
16. Miskala PH, Hawkins BS, Mangione CM, et al; Submacular Surgery Trials Research Group. Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization-SST Report No. 1. Arch Ophthalmol. 2003;121(4):531-539. (Pubitemid 36427640)
17. Graubard BI, Korn EL. Modelling the sampling design in the analysis of health surveys. Stat Methods Med Res. 1996;5(3):263-281. (Pubitemid 126559355)
18. Loftus JV, Sultan MB, Pleil AM; Macugen 1013 Study Group. Changes in vision-and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham. Invest Ophthalmol Vis Sci. 2011;52(10):7498-7505.
19. Dong LM, Childs AL, Mangione CM, et al; Submacular Surgery Trials Research Group. Health-and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4. Am J Ophthalmol. 2004;138(1):91-108. (Pubitemid 38850254)
20. Rubin GS, Muñoz B, Bandeen-Roche K, West SK. Monocular versus binocular visual acuity as measures of vision impairment and predictors of visual disability. Invest Ophthalmol Vis Sci. 2000;41(11):3327-3334.